Now showing items 5-24 of 117

      Approval Letter for Change of Name: Center for Vaccine Development and Global Health [1]
      Attenuated PfSPZ Vaccine Induces Strain-Transcending T Cells and Durable Protection Against Heterologous Controlled Human Malaria Infection [1]
      Bioactive Immune Components of Anti-Diarrheagenic Enterotoxigenic E. coli (ETEC) Hyperimmune Bovine Colostrum Products [1]
      Center for Vaccine Development (CVD): Harnessing the Power of Vaccines [1]
      Center for Vaccine Development's 24th Annual Frontiers in Vaccinology [1]
      Chest Radiograph Findings in Childhood Pneumonia Cases From the Multisite PERCH Study [1]
      Clinical Evaluation Phases 1,2,3,4 [1]
      Clinical Trials in the Developing World and Ebola Vaccine Development [1]
      A clinically parameterized mathematical model of Shigella immunity to inform vaccine design [1]
      Colonization Density of the Upper Respiratory Tract as a Predictor of Pneumonia--Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii [1]
      Combining Malaria and NTD Mass Treatment in Schools [1]
      Combining Malaria and NTD Mass Treatment in Schools Pilot Study of the Addition of Mass Treatment for Malaria to Existing School-Based Programs to Treat Neglected Tropical Diseases [1]
      Compositional and Functional Differences in the Human Gut Microbiome Correlate with Clinical Outcome following Infection with Wild-Type Salmonella enterica Serovar Typhi [1]
      The Critical Role Of Zinc in a New Murine Model of Enterotoxigenic E. coli (ETEC) Diarrhea [1]
      Cytokines are markers of the Clostridium difficile-induced inflammatory response and predict disease serverity [1]
      Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines [1]
      Deletion of the Major Facilitator Superfamily Transporter fptB Alters Host Cell Interactions and Attenuates Virulence of Type A Francisella tularensis [1]
      Deletion of the MFS transporter fptB alters host cell interactions and attenuates the virulence of Type A Francisella tularensis [1]
      Density of Upper Respiratory Colonization With Streptococcus pneumoniae Among Children Aged <5 Years in the PERCH Study [1]
      Detection of Shigella in direct stool specimens using a metagenomic approach [1]